We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Wins Lipitor Patent Challenge

Law360 (November 28, 2005, 12:00 AM EST) -- In a significant victory for Pfizer, Inc., the U.S. Patent and Trademark Office is planning to issue a re-examination certificate for a contested patent for its best-selling drug, the $9.2 billion cholesterol fighter Lipitor.

Last week, the USPTO examiner issued a Notice of Intent to Issue Ex Parte Re-Examination Certificate. Included in the allowed claims are 21 of the original claims, 13 amended claims and 73 newly presented claims, Frost Brown Todd LLC patent attorney Stephen R. Albainy-Jenei reported on his popular blog.

The development marks...
To view the full article, register now.